Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Medizen Humancare

Request full access

Genomic analysis service for personalized disease prediction

Seoul, South KoreaHealth

About Medizen Humancare

Medizen Humancare is a South Korean biotechnology company specializing in genomic analysis for personalized disease prediction and healthcare solutions. The company was founded in July 2012 by Dr. Shin, who holds a PhD in Genetics. A significant milestone was achieved in January 2016 when the company was listed on KONEX, the Korean stock exchange.

The core of Medizen Humancare's business is its genomic analysis services, which are designed to predict an individual's susceptibility to various diseases by analyzing their DNA from samples like blood or saliva. The company's main services include "M-CHECK," a disease prediction genome analysis system, and "Lifegene," a direct-to-consumer wellness genetic test. These services assess the genetic risk for a wide range of illnesses, including cancers and chronic diseases, by analyzing genomic data alongside environmental factors and lifestyle habits. Medizen Humancare has developed proprietary algorithms and maintains a large-scale genomic database, particularly for East Asian populations, which enhances the accuracy of its predictions.

The company serves a diverse client base that includes medical institutions, clinics, government agencies, and corporations. Its business model involves providing these institutions with genetic testing services and collaborating on research. The company also engages in the development of diagnostic kits and chips. Medizen Humancare has expanded its operations internationally, establishing joint ventures and partnerships in countries such as Indonesia, Malaysia, Vietnam, Mongolia, and Turkey to provide its services to a global market.

Source: Dealroom company data

Medizen Humancare in the Seoul ecosystem

Live from Dealroom

The Medizen Humancare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • LSK Investment
  • BNH
  • Industrial Bank of Korea
  • Woori Bank

Series B and later1 investor entered at this stage

  • GDK cosmetics
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇰🇷 South Korea · Seoul HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Medizen Humancare on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Medizen Humancare on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.